AMI eyes

Application area Ami Eyes

Designed for the delicate peri-orbital region, the Ami Eyes skin booster is used in mesotherapy-style injections to address fine wrinkles, under-eye texture change, and post-acne irregularities while supporting overall rejuvenation. Indicated for the infra-orbital/tear-trough area, it is supplied as a pre-filled 2 mL syringe containing 1% polynucleotide (20 mg) derived from salmon milt and refined to a specific molecular size for dermal use.

In practice, clinicians target the superficial to mid-dermis of the lower eyelid – cheek junction, aiming to improve elasticity, microcirculation, and dermal matrix quality in patients seeking evidence-based procedure protocols with measured results and predictable recovery times. This peri-ocular focus makes the product suitable where conservative, tissue-friendly ingredients and controlled dosing are required.

Strengths of Ami Eyes

Beyond simple hydration, the mechanism behind an Ami Eyes treatment is tied to PN-mediated bio-modulation: anti-inflammatory signaling, selective VEGF pathway activation to support neovascularization and blood-flow improvement, and nucleic-acid support for cell turnover and tissue remodeling.

Manufacturing highlights include high-purity processing, sterile quality controls, and a formulation free of preservatives and antibiotics, with humectant co-factors to aid skin moisture balance. A commonly cited frequency is a series of up to three sessions spaced roughly 20 – 30 days apart, allowing time for incremental matrix improvement.

Key technical points (from product specs):

• PN concentration: 1% (20 mg) in a single 2 mL pre-filled syringe.
• Intended zone: under-eye; administered as mesotherapy micro-deposits.
• Session plan: up to 3 sessions, approximately every 3 – 4 weeks.
• Aims: dampen pro-inflammatory cues, encourage capillary support, and promote collagenic/non-collagenic protein synthesis for dermal regeneration.

Who is This Product For

Candidates for the peri-orbital program are those with early photo-aging, fine-line etching, mild atrophic change, or texture dullness who prefer a staged approach rather than volumizing fillers. As with any skin booster, case selection weighs baseline health, eyelid anatomy, and expectations; documenting Ami Eyes before and after views typically follows a multi-session plan so clinicians can correlate time-linked changes to session spacing and technique variables. The product’s scope is professional-use only; it is positioned for trained practitioners who integrate under-eye treatment into broader esthetic pathways and who counsel patients on post-session care (e.g., transient edema/erythema typical of micro-depositing).

When used within the labeled under-eye area and cadence, the PN platform is intended to support elasticity, microvascular tone, and matrix renewal – complementing clinic protocols that prioritize measured outcomes over single-visit correction.